Combined administration of A2A receptor antagonist and 5-HT1A/1B receptor agonist reverses neuroinflammation in the 6-OHDA model of Parkinson's disease

被引：0
|
作者：
Pinna, A.
Costa, G.
Serra, M.
Morelli, M.
机构：
来源：
MOVEMENT DISORDERS | 2018年 / 33卷
关键词：
ANIMAL-MODELS; DYSKINESIA; A(2A);
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
355
引用
收藏
页码：S157 / S158
页数：2
相关论文
共 50 条
  • [31] Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior
    Uphouse, L
    White, S
    Harrison, L
    Hiegel, C
    Majumdar, D
    Guptarak, J
    Truitt, WA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 76 (01) : 63 - 73
  • [32] Repeated administration of the 5-HT1B/1A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT1A and 5-HT1B receptor mechanisms
    Dane Aronsen
    Natasha Bukholt
    Susan Schenk
    Psychopharmacology, 2016, 233 : 1339 - 1347
  • [33] Repeated administration of the 5-HT1B/1A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT1A and 5-HT1B receptor mechanisms
    Aronsen, Dane
    Bukholt, Natasha
    Schenk, Susan
    PSYCHOPHARMACOLOGY, 2016, 233 (08) : 1339 - 1347
  • [34] Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test
    Tatarczynska, E
    Klodzinska, A
    Stachowicz, K
    Chojnacka-Wójcik, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 487 (1-3) : 133 - 142
  • [35] Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats
    Tatarczynska, E
    Klodzinska, A
    Chojnacka-Wójcik, E
    POLISH JOURNAL OF PHARMACOLOGY, 2002, 54 (06): : 615 - 623
  • [36] Effects of combined administration of 5-HT1A or 5-HT1B receptor antagonists and antidepressant drugs in the forced swimming test in rats
    Tatarczynska, E
    Klodzinska, A
    Stachowicz, K
    Chojnacka-Wójcik, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S197 - S198
  • [37] 5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease
    Bezard, Erwan
    Gerlach, Irene
    Moratalla, Rosario
    Gross, Christian E.
    Jork, Reinhard
    NEUROBIOLOGY OF DISEASE, 2006, 23 (01) : 77 - 86
  • [38] Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease
    Lindenbach, David
    Dupre, Kristin B.
    Jaunarajs, Karen L. Eskow
    Ostock, Corinne Y.
    Goldenberg, Adam A.
    Bishop, Christopher
    BRAIN RESEARCH, 2013, 1537 : 327 - 339
  • [39] Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease
    Huot, Philippe
    Johnston, Tom H.
    Visanji, Naomi P.
    Darr, Tayyeba
    Pires, Donna
    Hazrati, Lili-Naz
    Brotchie, Jonathan M.
    Fox, Susan H.
    MOVEMENT DISORDERS, 2012, 27 (06) : 735 - 742
  • [40] SB-272183, a selective 5-HT1A, 5-HT1B and 5-HT1D receptor antagonist.
    Roberts, C
    Watson, J
    Scott, C
    Collin, L
    Harries, MH
    Wyman, P
    Gaster, L
    Price, GW
    Midlemiss, DN
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U76 - U76
12345